Enterotoxigenic Bacteroides fragilis에 의한 질환과 검출
Enterotoxigenic Bacteroides fragilis-Associated Diseases and Detection
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
These commensal intestinal bacteria can enhance the immune system and aid in nutrient absorption but can also act as opportunistic pathogens. Among these intestinal bacteria, the anaerobic Bacteroides fragilis are divided into enterotoxigenic B. fragilis (ETBF) which secrete the B. fragilis toxin (BFT) and non-enterotoxigenic B. fragilis (NTBF) which do not secrete BFT. ETBF can cause diarrhea and colitis in both humans and livestock but can also be found in asymptomatic individuals. ETBF is predominantly found in patients with inflammatory diarrheal diseases and traveller’s diarrhea. Several clinical studies have also reported an increased prevalence of ETBF in human patients with inflammatory bowel disease (IBD), colitis and colorectal cancer. In small animal models (C57BL/6 wild-type mice, germ-free mice, multiple intestinal neoplasia (Min) mice, rabbits and Mongolian gerbils), ETBF have been found to initiate and/or aggravate IBD, colitis and colorectal cancer. BFT induces E-cadherin cleavage in intestinal epithelial cells resulting in loss of epithelial cell integrity. Subsequent activation of the -catenin pathway leads to increased cellular proliferation. In addition, ETBF causes acute and chronic colitis in wild-type mice as well as enhances tumorigenesis in Min mice via activation of the Stat3/Th17 pathway. Currently, ETBF can be detected using a BFT toxin bioassay and by PCR. Advances in molecular biological techniques such as real-time PCR have allowed both researchers as well as clinicians to rapidly detect ETBF in clinical samples. The emergence of more sensitive techniques will likely advance molecular insight into the role of ETBF in colitis and cancer.
Abstract
These commensal intestinal bacteria can enhance the immune system and aid in nutrient absorption but can also act as opportunistic pathogens. Among these intestinal bacteria, the anaerobic Bacteroides fragilis are divided into enterotoxigenic B. fragilis (ETBF) which secrete the B. fragilis toxin (BFT) and non-enterotoxigenic B. fragilis (NTBF) which do not secrete BFT. ETBF can cause diarrhea and colitis in both humans and livestock but can also be found in asymptomatic individuals. ETBF is predominantly found in patients with inflammatory diarrheal diseases and traveller’s diarrhea. Several clinical studies have also reported an increased prevalence of ETBF in human patients with inflammatory bowel disease (IBD), colitis and colorectal cancer. In small animal models (C57BL/6 wild-type mice, germ-free mice, multiple intestinal neoplasia (Min) mice, rabbits and Mongolian gerbils), ETBF have been found to initiate and/or aggravate IBD, colitis and colorectal cancer. BFT induces E-cadherin cleavage in intestinal epithelial cells resulting in loss of epithelial cell integrity. Subsequent activation of the -catenin pathway leads to increased cellular proliferation. In addition, ETBF causes acute and chronic colitis in wild-type mice as well as enhances tumorigenesis in Min mice via activation of the Stat3/Th17 pathway. Currently, ETBF can be detected using a BFT toxin bioassay and by PCR. Advances in molecular biological techniques such as real-time PCR have allowed both researchers as well as clinicians to rapidly detect ETBF in clinical samples. The emergence of more sensitive techniques will likely advance molecular insight into the role of ETBF in colitis and cancer.
참고문헌 (54)
- Avila-Campos MJ, "Determination of bft gene subtypes in Bacteroides fragilis clinical isolates", J Clin Microbiol, 45, pp.1336~1338 (2007)
- Basset C, "Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease?", Dig Dis Sci, 49, pp.1425~1432 (2004)
- Chen LA, "Fecal detection of enterotoxigenic Bacteroides fragilis", Eur J Clin Microbiol Infect Dis, 34, pp.1871~1877 (2015)
- Chung GT, "Identification of a third metalloprotease toxin gene in extraintestinal isolates of Bacteroides fragilis", Infect Immun, 67, pp.4945~4949 (1999)
- Franco AA, "Cloning and characterization of the Bacteroides fragilis metalloprotease toxin gene", Infect Immun, 65, pp.1007~1013 (1997)
- Franco AA, "Molecular evolution of the pathogenicity island of enterotoxigenic Bacteroides fragilis strains", J Bacteriol, 181, pp.6623~6633 (1999)
- Jiang ZD, "Microbial etiology of travelers' diarrhea in Mexico, Guatemala, and India: importance of enterotoxigenic Bacteroides fragilis and Arcobacter species", J Clin Microbiol, 48, pp.1417~1419 (2010)
- Kim KH, "Isolation and transfer for R-plasmid of Bacteroides fragilis", Korean Journal of Medical Technologists, 22, pp.53~60 (1990)
- Kling JJ, "Cloning and characterization of the gene for the metalloprotease enterotoxin of Bacteroides fragilis", FEMS Microbiol Lett, 146, pp.279~284 (1997)
- Koshy SS, "Human intestinal epithelial cells swell and demonstrate actin rearrangement in response to the metalloprotease toxin of Bacteroides fragilis", Infect Immun, 64, pp.5022~5028 (1996)
- Lassmann B, "Reemergence of anaerobic bacteremia", Clin Infect Dis, 44, pp.895~900 (2007)
- Lee CS, "Evaluation of new gyrB-based real-time PCR system for the detection of B. fragilis as an indicator of human-specific fecal contamination", J Microbiol Methods, 82, pp.311~318 (2010)
- Lee CS, "A novel genetic marker for the rapid detection of Bacteroides fragilis in recreational water as a human-specific faecal indicator", J Water Health, 9, pp.253~264 (2011)
- Liu C, "Rapid identification of the species of the Bacteroides fragilis group by multiplex PCR assays using group- and species-specific primers", FEMS Microbiol Lett, 222, pp.9~16 (2003)
- Merino VR, "Quantitative detection of enterotoxigenic Bacteroides fragilis subtypes isolated from children with and without diarrhea", J Clin Microbiol, 49, pp.416~418 (2011)
- Miki T, "Simultaneous detection of Bacteroides fragilis group species by leuB-directed PCR", J Med Invest, 52, pp.101~108 (2005)
- Moncrief JS, "The enterotoxin of Bacteroides fragilis is a metalloprotease", Infect Immun, 63, pp.175~181 (1995)
- Moncrief JS, "Molecular characterization of the fragilysin pathogenicity islet of enterotoxigenic Bacteroides fragilis", Infect Immun, 66, pp.1735~1739 (1998)
- Mundy LM, "Detection of toxin production by Bacteroides fragilis: assay development and screening of extraintestinal clinical isolates", Clin Infect Dis, 23, pp.269~276 (1996)
- Myers LL, "Bacteroides fragilis: a possible cause of acute diarrheal disease in newborn lambs", Infect Immun, 44, pp.241~244 (1984)
- Myers LL, "Isolation of enterotoxigenic Bacteroides fragilis from humans with diarrhea", J Clin Microbiol, 25, pp.2330~2333 (1987)
- Myers LL, "Diarrheal disease caused by enterotoxigenic Bacteroides fragilis in infant rabbits", J Clin Microbiol, 27, pp.2025~2030 (1989)
- Neish AS, "Microbes in gastrointestinal health and disease", Gastroenterology, 136, pp.65~80 (2009)
- Ni Van, "Evaluation of Enterotoxigenic Bacteroides fragilis from Colonic Washings from Patients Undergoing Colonoscopy", 대한의생명과학회지, 18(4), pp.362~368 (2012), 대한의생명과학회
- Obiso RJ, Jr., "Proteolytic activity of the Bacteroides fragilis enterotoxin causes fluid se cretion and intestinal damage in vivo", Infect Immun, 63, pp.3820~3826 (1995)
- Papaparaskevas J, "Comparative evaluation of conventional and real-time PCR assays for detecting Bacteroides fragilis in clinical samples", J Clin Microbiol, 51, pp.1593~1595 (2013)
- Polk BF, "Bacteroides fragilis subspecies in clinical isolates", Ann Intern Med, 86, pp.569~571 (1977)
- Prindiville TP, "Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease", Emerg Infect Dis, 6, pp.171~174 (2000)
- Rabizadeh S, "Enterotoxigenic Bacteroides fragilis: a potential instigator of colitis", Inflamm Bowel Dis, 13, pp.1475~1483 (2007)
- Redondo MC, "Attributable mortality of bacteremia associated with the Bacteroides fragilis group", Clin Infect Dis, 20, pp.1492~1496 (1995)
- Rhee KJ, "Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL", 6 mice, 2009, pp.77, 1708~1718
- Rolfe RD, "Factors related to the oxygen tolerance of anaerobic bacteria", Appl Environ Microbiol, 36, pp.306~313 (1978)
- Sack RB, "qEnterotoxigenic Bacteroides fragilis: epidemiologic studies of its role as a human diarrhoeal pathogen", J Diarrhoeal Dis Res, 10, pp.4~9 (1992)
- Sack RB, "Isolation of enterotoxigenic Bacteroides fragilis from Bangladeshi children with diarrhea: a controlled study", J Clin Microbiol, 32, pp.960~963 (1994)
- Saidi RF, "Bacteroides fragilis toxin rapidly intoxicates human intestinal epithelial cells (HT29", C1) in vitro, 1996, pp.64, 5029~5034
- Sears CL, "Enterotoxigenic Bacteroides fragilis", Clin Infect Dis, 20(Suppl 2), pp.S142~S148 (1995)
- Sears CL, "The toxins of Bacteroides fragilis", Toxicon, 39, pp.1737~1746 (2001)
- Sears CL, "Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea", Clin Infect Dis, 47, pp.797~803 (2008)
- Sears CL, "Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes", Clin Microbiol Rev, 22, pp.349~369 (2009)
- Tong J, "Application of quantitative real-time PCR for rapid identification of Bacteroides fragilis group and related organisms in human wound samples", Anaerobe, 17, pp.64~68 (2011)
- Toprak NU, "A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer", Clin Microbiol Infect, 12, pp.782~786 (2006)
- Troy EB, "Beneficial effects of Bacteroides fragilis polysaccharides on the immune system", Front Biosci, 15, pp.25~34 (2010)
- Turnbaugh PJ, "The human microbiome project", Nature, 449, pp.804~810 (2007)
- Vines RR, "Fragilysin, the enterotoxin from Bacteroides fragilis, enhances the serum antibody response to antigen co-administered by the intranasal route", Vaccine, 19, pp.655~660 (2000)
- Weikel CS, "Human colonic epithelial cells, HT29", C1, treated with crude Bacteroides fragilis enterotoxin dramatically alter their morphology, 1992, pp.60, 321~327
- Wexler HM, "Bacteroides: the good, the bad, and the nitty-gritty", Clin Microbiol Rev, 20, pp.593~621 (2007)
- Wu S, "Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin", Proc Natl Acad Sci USA, 95, pp.14979~14984 (1998)
- Wu S, "Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation", Gastroenterology, 124, pp.392~400 (2003)
- Wu S, "Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin-8 through mitogen-activated protein kinases and a tyrosine kinase-regulated nuclear factor-B pathway", Infect Immun, 72, pp.5832~5839 (2004)
- Wu S, "The Bacteroides fragilis toxin binds to a specific intestinal epithelial cell receptor", Infect Immun, 74, pp.5382~5390 (2006)
- Wu S, "Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and gamma-secretase-dependent E-cadherin cleavage", J Cell Sci, 120, pp.1944~1952 (2007)
- Wu S, "A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses", Nat Med, 15, pp.1016~1022 (2009)
- Yim S, "Enterotoxigenic Bacteroides fragilis causes lethal colitis in Mongolian gerbils", Anaerobe, 21, pp.64~66 (2013)
- Zhang G, "Prevalence of enterotoxigenic Bacteroides fragilis in adult patients with diarrhea and healthy controls", Clin Infect Dis, 29, pp.590~594 (1999)